Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China · Delayed Price · Currency is CNY 9.69
+0.18 (1.89%)
Jun 1, 2026, 3:00 PM CST
SHA:603229 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 108.03 | 130.57 | 206.79 | 253.9 | 235.38 | 145.93 |
Depreciation & Amortization | 73.96 | 73.96 | 63.66 | 40.59 | 34.48 | 30.02 |
Other Amortization | 0.23 | 0.23 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | - | - | - | 1.58 | 0.52 |
Asset Writedown & Restructuring Costs | 1.48 | 1.48 | 0.15 | 5.62 | 4.95 | 5.24 |
Loss (Gain) From Sale of Investments | -22.28 | -22.28 | -28.05 | -0.4 | -5.4 | -7.9 |
Provision & Write-off of Bad Debts | -4.32 | -4.32 | 7.26 | 0.34 | - | - |
Other Operating Activities | 35.22 | 48.77 | 5.46 | -3.68 | -35.46 | 7.37 |
Change in Accounts Receivable | -9.12 | -9.12 | -23.03 | 34.45 | -69.41 | -101.89 |
Change in Inventory | -16.93 | -16.93 | -45.59 | -79.38 | -153.14 | -56.99 |
Change in Accounts Payable | -42.4 | -42.4 | -6.19 | -26.04 | 97.47 | 151.35 |
Change in Other Net Operating Assets | -0.09 | -0.09 | - | - | - | - |
Operating Cash Flow | 120.43 | 156.51 | 177.93 | 221.85 | 120.57 | 173.9 |
Operating Cash Flow Growth | -21.28% | -12.04% | -19.80% | 84.00% | -30.67% | 25.59% |
Capital Expenditures | -94.86 | -104.45 | -111.3 | -163.47 | -271.91 | -310.85 |
Sale of Property, Plant & Equipment | 0.11 | 0.11 | 0.04 | 0.19 | 0.19 | 0.21 |
Investment in Securities | -1.93 | -3.94 | -2.25 | -18 | 95.69 | -114.72 |
Other Investing Activities | 47.84 | 49.85 | -6.46 | 5.81 | -1.81 | -6.94 |
Investing Cash Flow | -48.84 | -58.42 | -119.97 | -175.47 | -177.85 | -432.3 |
Short-Term Debt Issued | - | - | - | 330 | - | - |
Long-Term Debt Issued | - | 505.18 | 270.1 | - | 235.05 | 219.8 |
Total Debt Issued | 516.39 | 505.18 | 270.1 | 330 | 235.05 | 219.8 |
Short-Term Debt Repaid | - | - | - | -271.7 | - | - |
Long-Term Debt Repaid | - | -321.3 | -300.94 | -0.63 | -103.15 | -151 |
Total Debt Repaid | -322.34 | -321.3 | -300.94 | -272.33 | -103.15 | -151 |
Net Debt Issued (Repaid) | 194.05 | 183.88 | -30.84 | 57.67 | 131.9 | 68.8 |
Issuance of Common Stock | - | - | - | 473.93 | - | - |
Repurchase of Common Stock | -50.01 | -50.01 | - | - | - | - |
Common Dividends Paid | -92.21 | -90.62 | -84.22 | -57.45 | -37.67 | -19.97 |
Other Financing Activities | 21.34 | 7.2 | 6.84 | -4.23 | 0.69 | -11.8 |
Financing Cash Flow | 73.16 | 50.45 | -108.22 | 469.93 | 94.92 | 37.03 |
Foreign Exchange Rate Adjustments | -43.38 | -17.46 | 10.84 | 7.95 | 37.18 | -10.63 |
Net Cash Flow | 101.37 | 131.08 | -39.42 | 524.25 | 74.82 | -232 |
Free Cash Flow | 25.56 | 52.06 | 66.62 | 58.38 | -151.35 | -136.95 |
Free Cash Flow Growth | -9.19% | -21.85% | 14.12% | - | - | - |
Free Cash Flow Margin | 3.22% | 6.57% | 8.38% | 7.15% | -19.80% | -24.04% |
Free Cash Flow Per Share | 0.03 | 0.06 | 0.08 | 0.07 | -0.19 | -0.17 |
Cash Income Tax Paid | 34.95 | 40.89 | 13.09 | -1.39 | 6.35 | 16.06 |
Levered Free Cash Flow | -105.87 | -19.8 | -64 | -108.01 | -179.91 | -29.41 |
Unlevered Free Cash Flow | -100.11 | -14.75 | -59.15 | -103.01 | -176.09 | -28.49 |
Change in Working Capital | -71.9 | -71.9 | -77.34 | -74.54 | -114.96 | -7.29 |